Who needs “normal”peptides?
If you ask anyone, “What is a peptide?”, you will probably get a stock answer involving a chain of 2 or more amino acids which link together via a “peptide” linkage (-C(O)-NH). You might learn there are 20 natural amino acids, and they are all in the same L- stereo configuration. You might also learn that they are great at getting the body to do stuff, but they don’t make great drugs because they have short half-lives. So, we need to modify natural peptides so that they behave more like drugs – we’ll find ways to make them more stable – but still have them doing all the nice things we like about them. We’ll cyclise them, stick fat on them, PEGylate them, conjugate them to make them better.
This article looks at some of the ways peptides are modified, but also recognises that unmodified peptides still have a role to play.
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.